Celecoxib's Effects on Breast Cancer in Rats
Author Information
Author(s): Woditschka Stephan, Haag Jill D, Mau Bob, Lubet Ronald A, Gould Michael N
Primary Institution: University of Wisconsin
Hypothesis
Can celecoxib prevent hormonally nonresponsive breast cancer in a rat model?
Conclusion
Celecoxib is effective in reducing tumor multiplicity in hormonally responsive mammary carcinomas but not in hormonally nonresponsive ones.
Supporting Evidence
- Celecoxib reduced tumor multiplicity by 56% in intact rats.
- No significant effect was found on hormonally nonresponsive tumors.
- Combination treatment with tamoxifen and celecoxib did not show additive effects.
Takeaway
Celecoxib helps prevent certain types of breast cancer in rats, but it doesn't work for all types.
Methodology
The study evaluated the effects of celecoxib on mammary carcinomas in a rat model, comparing hormonally responsive and nonresponsive tumors.
Limitations
The study was conducted in a rat model, which may not fully replicate human breast cancer.
Participant Demographics
Virgin Wistar–Furth female rats were used in the study.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website